Financial Data and Key Metrics Changes - Revenue in Q1 2023 increased by 70% to $45.3 million compared to $26.6 million in Q1 2022, while flight profit rose by 145% to $7.2 million from $2.9 million in the same period [24][39] - Adjusted EBITDA was a loss of $7.7 million, roughly flat year-over-year, but improved as a percentage of revenues to negative 17% from negative 29% [62][65] - Operating cash flow was a use of $16.9 million, primarily due to a $9.5 million investment in working capital [63] Business Line Data and Key Metrics Changes - Short Distance revenues increased by 148% to $10.4 million in Q1 2023, driven by the acquisition of Blade Europe and growth in Blade Airport service [15][25] - MediMobility Organ Transport revenue grew by 111% to $26.8 million, with organic growth attributed to new hospital wins and market expansion [38] - Jet and Other revenue declined by 17% to $8.1 million, driven by lower volume and average price per jet charter [19] Market Data and Key Metrics Changes - In the US, the number of Airport Passes sold increased by 118% year-to-date compared to the same period last year, indicating strong customer acquisition [8] - In Canada, revenue increased by 65% year-over-year, reflecting a recovery in demand [35] - European performance was impacted by weather and maintenance delays, but preparations are in place for peak season events [9][10] Company Strategy and Development Direction - The company is focused on optimizing marketing spend and enhancing customer acquisition through targeted campaigns [7] - Strategic bolt-on acquisitions are being evaluated to accelerate profitability while leveraging existing infrastructure and technology [12] - The transition to Electric Vertical Aircraft (EVA) is seen as a long-term growth opportunity, with ongoing efforts to improve operational efficiency [32][67] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving significant improvement in full-year adjusted EBITDA for 2023 compared to 2022 [6] - The company remains optimistic about the recovery in travel demand and the potential for increased bookings in Europe during the summer [57] - Management highlighted the importance of perfusion technology in expanding the addressable market for organ transport [36] Other Important Information - The company maintains a strong balance sheet with zero debt and approximately $179 million in cash and short-term securities [65] - New board members were appointed to enhance strategic oversight and support growth initiatives [31] Q&A Session Summary Question: What drove the increase in average pricing and revenue? - Management indicated that both volume increase and higher pricing contributed to revenue growth, with average pricing reaching $281 per seat [69][70] Question: What is driving the lower volume and pricing in the Jet business? - The decline is attributed to normalization post-Omicron demand, with many customers returning to commercial flights [53][60] Question: How does the company view the impact of perfusion technology on flight margins? - Perfusion technology is expected to increase the number of organs available for transport, positively impacting revenue and flight profit growth [88][90] Question: What are the expectations for flight margin progress in the upcoming quarters? - Flight profit margins are expected to improve to the high-teens in Q2 and further in Q3, which is typically the strongest quarter [111]

See Note 8, "Commitments and Contingencies", for additional information about our capacity purchase agreements. Balance sheet information related to the Company's leases is presented below: | --- | --- | --- | --- | --- | |--------------------------------------------|-------|--------------------|-------|---------------------| | Operating leases: | | March 31, 2023 | | December 31, 2022 | | Operating right-of-use asset | $ | 24,092 | $ | 17,692 | | Operating lease liability, current | | 4,029 | | 3,362 | | O ...

TABLE OF CONTENTS 2 bl f C Table of Contents bl f C NOTE REGARDING FORWARD–LOOKING STATEMENTS This Annual Report on Form 10-K may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements can generally be identified using forward-looking terminology, including the terms "believes", "estimates", "anticipates, "expects", "seeks", "projects", "intends", plans," "may", "will" or "should" or, in each case, their negative or o ...

Blade Air Mobility, Inc. (NASDAQ:BLDE) Q4 2022 Earnings Conference Call March 14, 2023 8:00 AM ET Company Participants Ravi Jani - Vice President of Investor Relations Rob Wiesenthal - Founder and Chief Executive Officer Will Heyburn - Chief Financial Officer Conference Call Participants Jason Helfstein - Oppenheimer Bill Peterson - J.P. Morgan Hillary Cacanando - Deutsche Bank Stephen Ju - Credit Suisse Itay Michaeli - Citi Operator Good day, ladies and gentlemen, and welcome to the Blade Air Mobility Fisc ...

BLADE March 2023 FORWARD LOOKING STATEMENTS Such forward-looking statements are subject to known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside Blade's control, that could cause actual results to differ materially from the results discussed in the forward-looking statements. Factors that could cause actual results to differ materially from those expressed or implied in forward-looking statements include: our continued incurrence of significant losses; th ...

Table of Contents bl f C UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: September 30, 2022 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the transition period from to Commission File Number 001-39046 BLADE AIR MOBILITY, INC. | --- | --- | --- | --- | --- | |--------------------------------- ...

Blade Air Mobility, Inc. (NASDAQ:BLDE) Q3 2022 Earnings Conference Call November 9, 2022 4:30 PM ET Company Participants Ravi Jani - VP, IR Robert Wiesenthal - Founder and CEO William Heyburn - CFO Conference Call Participants Jason Helfstein - Oppenheimer Hillary Cacanando - Deutsche Bank Stephen Ju - Credit Suisse Operator Good day, and thank you for standing by. Welcome to the Blade Air Mobility Inc. Fiscal Third Quarter 2022 Earnings Call. At this time, all participants are in a listen-only mode. After ...

Blade Air Mobility, Inc. (NASDAQ:BLDE) Q2 2022 Earnings Conference Call August 9, 2022 8:00 AM ET Company Participants Ravi Jani - VP, IR Robert Wiesenthal - CEO & Director Melissa Tomkiel - President William Heyburn - CFO & Head, Corporate Development Conference Call Participants Hillary Cacanando - Deutsche Bank Stephen Ju - Crédit Suisse William Peterson - JPMorgan Chase & Co. Jason Helfstein - Oppenheimer Itay Michaeli - Citigroup Operator Good morning, and welcome to the Blade Urban Air Mobility Inc. F ...

Table of Contents bl f C UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2022 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the transition period from to Commission File Number 001-39046 BLADE AIR MOBILITY, INC. | --- | --- | --- | --- | --- | |-------------------------------------- ...

Investor Presentation – May 10, 2022 Forward Looking Statements This presentation contains "forward-looking statements" within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements that are not historical facts and may be identified by the use of words such as "anticipate", "believe", "could", "continue", "expect", "estimate", "may", "plan", "outlook", "scheduled," "future" and "project" and other similar expres ...